Clinical Studies of Gemcitabine-Oxaliplatin

StatusCompleted
PhasePhase 2

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study Status, Sponsor/Collaborators, Referencesv5
  2. Trial status: Recruiting to Completed
    • Site details revised
    v4
  3. Eligibility criteria expanded, about 9 words
    • Site contact updated
    • Study title shortened, about 2 words
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
These are Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory or relapsing pediatric solid tumors.
Trial Details
NCT Number NCT00407433
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions
(from sponsor)		 Medulloblastoma, Central Nervous System Tumors, Neuroblastoma, Osteosarcoma
Related terms Central Nervous System Neoplasms, Medulloblastoma, Neuroblastoma, Osteosarcoma
Enrollment 156 participants
Updated on ClinicalTrials.gov